What is Intrapharm Laboratories?
Based in the United Kingdom, Intrapharm Laboratories operates as a specialized entity focused on the commercialization of pharmaceutical products. The firm provides critical expertise to the healthcare sector, bridging the gap between product registration and patient delivery. As a key member of the Riemser Group of Companies, Intrapharm maintains a robust portfolio that spans both niche and branded pharmaceuticals. Their business model is predicated on forming successful, forward-thinking partnerships that ensure a flexible and reliable service delivery, effectively managing the lifecycle of medical products from initial development to final market distribution.
How much funding has Intrapharm Laboratories raised?
Intrapharm Laboratories has raised a total of $3.3M across 1 funding round:
Private Equity
$3.3M
Private Equity (2014): $3.3M with participation from Business Growth Fund
Key Investors in Intrapharm Laboratories
Business Growth Fund
BGF is a prominent investment firm based in London, recognized as a leading provider of growth capital to small and mid-sized businesses across the United Kingdom.
What's next for Intrapharm Laboratories?
With the support of major strategic capital, Intrapharm Laboratories is well-positioned to accelerate its growth strategy. The firm is expected to focus on expanding its product portfolio and deepening its penetration into both domestic and international healthcare markets. By maintaining its commitment to professional excellence and strategic partnerships, the company aims to capitalize on its current momentum to drive long-term value. Future initiatives will likely involve scaling its registration-to-patient infrastructure, ensuring that the organization remains a reliable partner for healthcare providers while navigating the complexities of the global pharmaceutical regulatory environment.
See full Intrapharm Laboratories company page
